Smartphone-assisted exposure therapy for panic disorder and agoraphobia: an effectiveness study

Phase 2

• Conditions: F41.0; F40.0; Panic disorder [episodic paroxysmal anxiety]; Agoraphobia

• Registration Number: DRKS00022204
• Lead Sponsor: Klinik und Poliklinik für Psychiatrie und Psychotherapie Universitätsklinikum Bonn

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2020-10-29
• Study Completion: 2023-01-11
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 111

Inclusion Criteria

Age between 18 and 60 years, fulfilment of the diagnostic criteria for a panic disorder and/or agoraphobia as defined in the DSM-5, at least 2 panic attacks within the last 2 weeks

Exclusion Criteria

Acute psychosis, pregnancy, insufficient knowledge of the german language, instable cardiovascular deseases/uncontrolled high blood pressure, other medical conditions that conflict the conduction of an exposure therapy

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
After a 5-week intervention, the severity of the anxiety symptoms will be recorded by means of the questionnaires AKV, PAS, DASS, ASI, TSMS, SWE, WHOQOL-BREF, which are digitized and available in SosciSurvey.<br>Furthermore, the app usage behaviour and user satisfaction is evaluated by means of the respective app.

Secondary Outcome Measures

Name	Time	Method
In the follow-up measurement after 8 weeks, the primary outcome parameters are again determined using the same instruments.